Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis. uri icon

authors

  • Meng, Lingbin
  • Folefac, Edmund
  • Monk, Paul
  • Yang, Yuanquan
  • Sarah P. Psutka MD MS
  • Gheeya, Jinesh
  • Li, Mingjia
  • Noonavath, Meghana
  • Orcutt, Delaney
  • Gross, Evan
  • Collier, Katharine A
  • Mortazavi, Amir

publication date

  • September 22, 2025